Exact Mass: 456.272304
Exact Mass Matches: 456.272304
Found 500 metabolites which its exact mass value is equals to given mass value 456.272304
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phytyl diphosphate
Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids. [HMDB]. Phytyl diphosphate is found in many foods, some of which are highbush blueberry, wild leek, evergreen huckleberry, and allium (onion). Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids.
D1927
C21H36N4O5S (456.24062860000004)
Lucidenic acid F
Lucidenic acid F is found in mushrooms. Lucidenic acid F is a constituent of Ganoderma lucidum (reishi). Constituent of Ganoderma lucidum (reishi). Lucidenic acid F is found in mushrooms.
Lucidenolactone
Metabolite of Ganoderma lucidum (reishi). Lucidenolactone is found in mushrooms. Lucidenolactone is found in mushrooms. Metabolite of Ganoderma lucidum (reishi
Sulfolithocholic acid
C24H40O6S (456.25454600000006)
Sulfolithocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID:11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.
Rigin
Rigin (glycyl-L-glutaminyl-L-prolyl-L-arginine) is a tetrapeptide with functions similar to those of tuftsin. [HMDB] Rigin (glycyl-L-glutaminyl-L-prolyl-L-arginine) is a tetrapeptide with functions similar to those of tuftsin.
N-Docosahexaenoyl Glutamine
C27H40N2O4 (456.29879200000005)
N-docosahexaenoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Glutamine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Rhodamine B hydrazide
C28H32N4O2 (456.25251319999995)
N-[(2S)-1-[[(2S)-1-Amino-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide
Zatebradine
1-Acetyl-17-(3,3-dimethyloxiranyl)-1,2,3,8a,9,14,15,16a-octahydro-9-methyl-13,16-methano-8H,16H-pyrrolo[2,3:2,3]pyrido[4,3-o]quinindoline
C28H32N4O2 (456.25251319999995)
13Z-Labdene-8alpha,15,16-triol 8-beta-L-xylopyranoside
20(21)-Dehydrolucidenic acid A
20(21)-Dehydrolucidenic acid A is a natural product found in Ganoderma sinense and Ganoderma lucidum with data available.
[(3R,4S,8S,8aS)-3-hydroxy-6,8a-dimethyl-8-[(Z)-2-methylbut-2-enoyl]oxy-3-propan-2-yl-1,2,3a,4,5,8-hexahydroazulen-4-yl] 4-hydroxybenzoate
11-O-acetyl-8-epi-torilolone 8-O-beta-D-glucopyranoside
24,25-dihydro-27-desoxywithaferin A|27-desoxy-24,25-dihydrowithaferin A
(20R,22R)-3beta,20-dihydroxy-1-oxowitha-5,24-dienolide|3beta,20alphaF-dihydroxy-1-oxo-(22R)-witha-5,24-dienolide|3beta,20alphaF-dihydroxy-1-oxo-20R,22R-witha-5,24-dienolide
(7R,8R)-7-hydroxy-3-(4-hydroxy-2-methyl-6-oxocyclohexenyl)-7-methyl-8-(3-methyl-2-oxononyl)-7,8-dihydro-isochromene-6-one|cohaerin F
12alpha-acetoxy-24-methyl-24-oxoscalar-16-en-22,25-dial
15-hydroxy-13-epi-manoyl oxide-14-O-alpha-L-arabinopyranoside|tarapacol-14-O-alpha-L-arabinopyranoside
2,3-Dihydro-(4beta,22R)-4,27-Dihydroxy-1-oxowitha-2,5,24-trienolide
(1S,4R,7S,8aR)-4-((2E,4E)-6,8-dimethyldeca-2,4-dienyloxy)-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,6,7,8,8a-octahydronaphthalene-1-carboxylic acid|07H239-A
8-methoxy-9-hydroxy-3,10-diheptyl-2H,5H-pyran[5,6-c][1]benzopyran-2,5-dione|fordianin B
22-acetoxy-24-methyl-12,24-dioxoscalar-16-en-25-al
2-[12-(3,4-Methylenedioxyphenyl)dodecyl]-4-hydroxy-2,3,4,6,7,8-hexahydro-5H-1-benzopyran-5-one
5,7-dihydroxy-4-(1-hydroxypropyl)-6-(2-methyl-1-oxobutyl)-8-(3,7-dimethyl-2,6-octadienyl)-2H-benzopyran-2-one|kayeassamin C
24,25-Didehydro-(4beta,5beta,6beta,22R,24S,25R)-4-Hydroxy-5,6-epoxy-1-oxowithanolide
6alpha-hydroxy-17-phenylacetoxy-18-oxo-kolav-3-en-15-ol
17-formyl-19-hydroxy-11-methoxy-3,15,20-trimethyl-corynane-16-carboxylic acid methyl ester
(-)-5,7-dihydroxy-4-(1S-hydroxypropyl)-6-(3-methyl-1-oxobutyl)-8-(3,7-dimethyl-2,6-octadienyl)-2H-benzopyran-2-one|kayeassamin D
12alpha-hydroxy-5,13-dioxoisohalidrol|12beta-hydroxy-513-dioxoisohalidrol
methyl (2beta,12beta,19alpha)-1-[(2E)-3-phenylprop-2-enoyl]aspidospermidin-21-oate|N1-cinnamoyl-12-demethoxycylindrocarine
(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17,20-dibutanoate
3-[(2E,6E,10E)-11-carboxy-3,7,15-trimethyl-2,6,10,14-hexadecatetraenyl]-4,5-dihydroxybenzoic acid
9-Hydroxy-gamma-geraniol-1-O-(6-acetyl-3-angelyl)-beta-D-glucopyranoside|9-Hydroxy-gamma-geraniol-1-O-<6-acetyl-3-angelyl>-beta-D-glucopyranoside
Estra-1,3,5(10)-triene-3,16|A,17|A-triol tripropionate
2,6-diheptyl-3,6-dihydroxy-7-methoxy-dibenzofuran-1,4-dione|fordianaquinone B
Lucidenic acid F
Lucidenic acid F is a triterpenoid. Lucidenic acid F is a natural product found in Ganoderma lucidum with data available.
C27H36O6_1-Naphthalenecarboxylic acid, 8-(benzoyloxy)decahydro-7-hydroxy-5-[(3Z)-5-hydroxy-3-methyl-3-penten-1-yl]-1,4a-dimethyl-6-methylene
C27H36O6_Benzoic acid, 4-hydroxy-, (3R,4S,8S,8aS)-1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-8-[[(2Z)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-azulenyl ester
C27H36O6_Benzoic acid, 4-hydroxy-, 1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-8-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-azulenyl ester
3a-Sulfooxy-5b-cholanic acid
C24H40O6S (456.25454600000006)
BA-139-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
Ala Asn Pro Arg
Ala Asn Arg Pro
Ala Pro Asn Arg
Ala Pro Arg Asn
Ala Arg Asn Pro
Ala Arg Pro Asn
Asp Ile Ile Pro
Asp Ile Leu Pro
Asp Ile Pro Ile
Asp Ile Pro Leu
Asp Leu Ile Pro
Asp Leu Leu Pro
Asp Leu Pro Ile
Asp Leu Pro Leu
Asp Pro Ile Ile
Asp Pro Ile Leu
Asp Pro Leu Ile
Asp Pro Leu Leu
Glu Ile Pro Val
Glu Ile Val Pro
Glu Leu Pro Val
Glu Leu Val Pro
Glu Pro Ile Val
Glu Pro Leu Val
Glu Pro Val Ile
Glu Pro Val Leu
Glu Val Ile Pro
Glu Val Leu Pro
Glu Val Pro Ile
Glu Val Pro Leu
Phe Pro Pro Pro
Gly Lys Pro Arg
Gly Lys Arg Pro
Gly Pro Lys Arg
Gly Pro Gln Arg
Gly Pro Arg Lys
Gly Pro Arg Gln
Gly Gln Pro Arg
Gly Gln Arg Pro
Gly Arg Lys Pro
Gly Arg Pro Lys
Gly Arg Pro Gln
Gly Arg Gln Pro
His Ile Ser Thr
C19H32N6O7 (456.23323619999996)
His Ile Thr Ser
C19H32N6O7 (456.23323619999996)
His Leu Ser Thr
C19H32N6O7 (456.23323619999996)
His Leu Thr Ser
C19H32N6O7 (456.23323619999996)
His Ser Ile Thr
C19H32N6O7 (456.23323619999996)
His Ser Leu Thr
C19H32N6O7 (456.23323619999996)
His Ser Thr Ile
C19H32N6O7 (456.23323619999996)
His Ser Thr Leu
C19H32N6O7 (456.23323619999996)
His Thr Ile Ser
C19H32N6O7 (456.23323619999996)
His Thr Leu Ser
C19H32N6O7 (456.23323619999996)
His Thr Ser Ile
C19H32N6O7 (456.23323619999996)
His Thr Ser Leu
C19H32N6O7 (456.23323619999996)
His Thr Thr Val
C19H32N6O7 (456.23323619999996)
His Thr Val Thr
C19H32N6O7 (456.23323619999996)
His Val Thr Thr
C19H32N6O7 (456.23323619999996)
Ile Asp Ile Pro
Ile Asp Leu Pro
Ile Asp Pro Ile
Ile Asp Pro Leu
Ile Glu Pro Val
Ile Glu Val Pro
Ile His Ser Thr
C19H32N6O7 (456.23323619999996)
Ile His Thr Ser
C19H32N6O7 (456.23323619999996)
Ile Ile Asp Pro
Ile Ile Pro Asp
Ile Leu Asp Pro
Ile Leu Pro Asp
Ile Met Pro Pro
C21H36N4O5S (456.24062860000004)
Ile Asn Asn Pro
C19H32N6O7 (456.23323619999996)
Ile Asn Pro Asn
C19H32N6O7 (456.23323619999996)
Ile Pro Asp Ile
Ile Pro Asp Leu
Ile Pro Glu Val
Ile Pro Ile Asp
Ile Pro Leu Asp
Ile Pro Met Pro
C21H36N4O5S (456.24062860000004)
Ile Pro Asn Asn
C19H32N6O7 (456.23323619999996)
Ile Pro Pro Met
C21H36N4O5S (456.24062860000004)
Ile Pro Val Glu
Ile Ser His Thr
C19H32N6O7 (456.23323619999996)
Ile Ser Thr His
C19H32N6O7 (456.23323619999996)
Ile Thr His Ser
C19H32N6O7 (456.23323619999996)
Ile Val Glu Pro
Ile Val Pro Glu
Lys Gly Pro Arg
Lys Gly Arg Pro
Lys Asn Pro Val
Lys Asn Val Pro
Lys Pro Gly Arg
Lys Pro Asn Val
Lys Pro Arg Gly
Lys Pro Val Asn
Lys Arg Gly Pro
Lys Arg Pro Gly
Lys Val Asn Pro
Lys Val Pro Asn
Leu Asp Ile Pro
Leu Asp Leu Pro
Leu Asp Pro Ile
Leu Asp Pro Leu
Leu Glu Pro Val
Leu Glu Val Pro
Leu Ile Asp Pro
Leu Ile Pro Asp
Leu Leu Asp Pro
Leu Leu Pro Asp
Leu Met Pro Pro
C21H36N4O5S (456.24062860000004)
Leu Pro Asp Ile
Leu Pro Asp Leu
Leu Pro Glu Val
Leu Pro Ile Asp
Leu Pro Leu Asp
Leu Pro Met Pro
C21H36N4O5S (456.24062860000004)
Leu Pro Pro Met
C21H36N4O5S (456.24062860000004)
Leu Pro Val Glu
Leu Val Glu Pro
Leu Val Pro Glu
Met Ile Pro Pro
C21H36N4O5S (456.24062860000004)
Met Leu Pro Pro
C21H36N4O5S (456.24062860000004)
Met Pro Ile Pro
C21H36N4O5S (456.24062860000004)
Met Pro Leu Pro
C21H36N4O5S (456.24062860000004)
Met Pro Pro Ile
C21H36N4O5S (456.24062860000004)
Met Pro Pro Leu
C21H36N4O5S (456.24062860000004)
Asn Ala Pro Arg
Asn Ala Arg Pro
Asn Lys Pro Val
Asn Lys Val Pro
Asn Pro Ala Arg
Asn Pro Lys Val
Asn Pro Arg Ala
Asn Pro Val Lys
Asn Arg Ala Pro
Asn Arg Pro Ala
Asn Val Lys Pro
Asn Val Pro Lys
Pro Ala Asn Arg
Pro Ala Arg Asn
Pro Asp Ile Ile
Pro Asp Ile Leu
Pro Asp Leu Ile
Pro Asp Leu Leu
Pro Glu Ile Val
Pro Glu Leu Val
Pro Glu Val Ile
Pro Glu Val Leu
Pro Phe Pro Pro
Pro Gly Lys Arg
Pro Gly Gln Arg
Pro Gly Arg Lys
Pro Gly Arg Gln
Pro Ile Asp Ile
Pro Ile Asp Leu
Pro Ile Glu Val
Pro Ile Ile Asp
Pro Ile Leu Asp
Pro Ile Met Pro
C21H36N4O5S (456.24062860000004)
Pro Ile Pro Met
C21H36N4O5S (456.24062860000004)
Pro Ile Val Glu
Pro Lys Gly Arg
Pro Lys Asn Val
Pro Lys Arg Gly
Pro Lys Val Asn
Pro Leu Asp Ile
Pro Leu Asp Leu
Pro Leu Glu Val
Pro Leu Ile Asp
Pro Leu Leu Asp
Pro Leu Met Pro
C21H36N4O5S (456.24062860000004)
Pro Leu Pro Met
C21H36N4O5S (456.24062860000004)
Pro Leu Val Glu
Pro Met Ile Pro
C21H36N4O5S (456.24062860000004)
Pro Met Leu Pro
C21H36N4O5S (456.24062860000004)
Pro Met Pro Ile
C21H36N4O5S (456.24062860000004)
Pro Met Pro Leu
C21H36N4O5S (456.24062860000004)
Pro Asn Ala Arg
Pro Asn Lys Val
Pro Asn Arg Ala
Pro Asn Val Lys
Pro Pro Phe Pro
Pro Pro Ile Met
C21H36N4O5S (456.24062860000004)
Pro Pro Leu Met
C21H36N4O5S (456.24062860000004)
Pro Pro Met Ile
C21H36N4O5S (456.24062860000004)
Pro Pro Met Leu
C21H36N4O5S (456.24062860000004)
Pro Pro Pro Phe
Pro Gln Gly Arg
Pro Gln Arg Gly
Pro Arg Ala Asn
Pro Arg Gly Lys
Pro Arg Gly Gln
Pro Arg Lys Gly
Pro Arg Asn Ala
Pro Arg Gln Gly
Pro Val Glu Ile
Pro Val Glu Leu
Pro Val Ile Glu
Pro Val Lys Asn
Pro Val Leu Glu
Pro Val Asn Lys
Gln Gly Pro Arg
Gln Gly Arg Pro
sulfolithocholic acid
C24H40O6S (456.25454600000006)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Gln Pro Gly Arg
Gln Pro Arg Gly
Gln Arg Gly Pro
Gln Arg Pro Gly
Arg Ala Asn Pro
Arg Ala Pro Asn
Arg Gly Lys Pro
Arg Gly Pro Lys
Arg Gly Pro Gln
Arg Gly Gln Pro
Arg Lys Gly Pro
Arg Lys Pro Gly
Arg Asn Ala Pro
Arg Asn Pro Ala
Arg Pro Ala Asn
Arg Pro Gly Lys
Arg Pro Gly Gln
Arg Pro Lys Gly
Arg Pro Asn Ala
Arg Pro Gln Gly
Arg Gln Gly Pro
Arg Gln Pro Gly
Val Glu Ile Pro
Val Glu Leu Pro
Val Glu Pro Ile
Val Glu Pro Leu
Val Ile Glu Pro
Val Ile Pro Glu
Val Lys Asn Pro
Val Lys Pro Asn
Val Leu Glu Pro
Val Leu Pro Glu
Val Asn Lys Pro
Val Asn Pro Lys
Val Pro Glu Ile
Val Pro Glu Leu
Val Pro Ile Glu
Val Pro Lys Asn
Val Pro Leu Glu
Val Pro Asn Lys
PG(14:0/0:0)[U]
24,24-Difluoro-1,25,26-trihydroxyvitamin D3
N-docosahexaenoyl glutamine
C27H40N2O4 (456.29879200000005)
Lucidenolactone
Zatebradine
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
(4S)-3-[(2S,4S)-4-azido-4-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-2-propan-2-ylbutanoyl]-4-benzyl-1,3-oxazolidin-2-one
1,3-Benzodioxole,5-[bis[2-(2-butoxyethoxy)ethoxy]methyl]-
1-(3-chloro-4-methylphenyl)-4-[6-[4-(2-methylbutan-2-yl)phenoxy]hexyl]piperazine
C28H41ClN2O (456.29072460000003)
2,2-[(1-methylethylidene)bis[4,1-phenyleneoxy(1-methyl-2,1-ethanediyl)oxymethylene]]bis-Oxirane
butyl 2-methylprop-2-enoate,butyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid
1,3,5-Tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene
Pipendoxifene
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
N-[1-[(1-amino-1-oxopropan-2-yl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N-hydroxy-2-(2-methylpropyl)butanediamide
Tolypodiol
A diterpenoid natural product obtained from the cyanobacterium Tolypothrix nodosa. It shows strong anti-inflammatory activity in the mouse ear edema assay.
N-[(4-dimethylaminophenyl)methyl]-7-methoxy-N-(4-propan-2-ylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide
n4-Hydroxy-2-isobutyl-n1-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-yl)-succinamide
N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
2-[4-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]butyl]guanidine
1-tetradecanoyl-sn-glycero-3-phospho-(1-sn-glycerol)
[(1S,2R,3S,4S,5R)-5-azaniumyl-2-[(2R,3R,6S)-3-azaniumyl-6-(azaniumylmethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5S,6R)-4-azaniumyl-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]azanium
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tetradecanoate
Rhodamine B hydrazide
C28H32N4O2 (456.25251319999995)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
5-amino-2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-5-oxopentanoic acid
C27H40N2O4 (456.29879200000005)
Xyloketal A
A xyloketal with formula C27H36O6. It was initially isolated from the mangrove fungus Xylaria sp. from the South China sea coast.
(2E,6Z)-13-hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,14-triene-5,12-dione
A meroterpenoid that is hexadeca-2,6,14-triene-5,12-dione substituted by a hydroxy group at position 13, a 2-hydroxy-5-methoxy-3-methylphenyl group at position 1 and methyl groups at positions 3, 7, 11 and 15. Isolated from Halidrys siliquosa, it exhibits antibacterial and antifouling activities.
(10Z,14E)-2,6,10,14-Tetramethyl-5-hydroxy-16-(2-hydroxy-3-methyl-5-methoxyphenyl)-2,10,14-hexadecatriene-4,12-dione
(10E,14E)-5-hydroxy-16-(2-hydroxy-5-methoxy-3-methylphenyl)-2,6,10,14-tetramethylhexadeca-2,10,14-triene-4,12-dione
(2E,6E)-13-Hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,14-triene-5,12-dione
Strongylophorine-26
A diterpenoid that is 15,17-epoxypodocarpan-15-one substituted by a hydroxy group at position 13, methyl groups at positions 8 and 13 and a (5-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl)methyl group at position 14 (the 13alpha,14beta stereoisomer). Isolated from the marine sponge Petrosia corticata, it exhibits antineoplastic activity.
23-Deoxypaeonenoide A, (rel)-
A natural product found in Paeonia rockii subspeciesrockii.
2-[4-[2-(3,5-dimethoxyanilino)-2-oxoethyl]-1-piperazinyl]-N-(4-ethoxyphenyl)acetamide
8-benzoyloxy-7-hydroxy-5-[(Z)-5-hydroxy-3-methylpent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid
N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-oxo-1-[(phenylmethyl)amino]propan-2-yl]cyclopropyl]-phenylmethyl]carbamic acid (phenylmethyl) ester
N-[2-(3,4-dimethoxyphenyl)ethyl]-1-[(3,4-dimethoxyphenyl)methyl]-N-methyl-3-piperidinecarboxamide
[(1S,5R)-8-methyl-8-[(4-phenylphenyl)methyl]-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-N-(3-morpholin-4-ylpropyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-N-(3-morpholin-4-ylpropyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-(4-morpholinyl)ethanone
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-(4-oxanylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
N-[(2R,3R,4aS,6S,8aS)-2-[2-[4-(1-cyclohexenyl)phenyl]ethyl]-6-(hydroxymethyl)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-3-yl]-2-(dimethylamino)acetamide
C27H40N2O4 (456.29879200000005)
(2S)-N-[3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-2-[[4-(2,5-dioxopyrrolidin-1-yl)-2-sulfanylbutanoyl]amino]-4-methylpentanamide
C21H36N4O5S (456.24062860000004)
1-({(1s,4s,6s)-6-Isopropyl-3-methyl-4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-2-cyclohexen-1-yl}methyl)-3-(3-methoxyphenyl)urea
(5S,12R)-dihydroxy-(6R)-cysteinyl-(7E,9E,14Z)-icosatrienoate
C23H38NO6S- (456.24197080000005)
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetradecanoate
2,3-Dihydroxypropyl (2-hydroxy-3-pentadecoxypropyl) hydrogen phosphate
(E)-3,7,11,15-tetramethylhexadec-2-en-1-yl diphosphate
(12R)-hydroxy-10,11-dihydroleukotriene E4(1-)
C23H38NO6S (456.24197080000005)
An icosanoid anion that is the conjugate base of (12R)-hydroxy-10,11-dihydroleukotriene E4, obtained by deprotonation of the carboxy group; major species at pH 7.3.
TG(24:7)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
NA-Gln 22:6(4Z,7Z,10Z,13Z,16Z,19Z)
C27H40N2O4 (456.29879200000005)
TAPI-0
TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM. TAPI-0 is a MMP inhibitor and also attenuates TNF-α processing[1][2].